|
ABOUT COMPANY
Matinas BioPharma Holdings, Inc., a clinical-stage biopharmaceutical company, is focused on the discovery and development of several candidate products. The company is headquartered in Bedminster, New Jersey.
|
EARNINGS
Gross Profit (TTM): -14200585
Market Capitalization: 227060000
Operating Margin (TTM): -255.75
PE Ratio: None
PEG Ratio: 0
Profit Margin: 0
Revenue Per Share (TTM): 0
Revenue (TTM): 95830
Quarterly Earnings Growth YOY: 0
Quarterly Revenue Growth YOY: 0
Trailing PE: -
|
DIVIDENDS
Diluted EPS (TTM): -0.114
Dividend Date: None
Dividend Per Share: None
Dividend Yield: 0%
EBITDA: -15456706
ExDividend Date: None
Forward Annual Dividend Rate:
Forward Annual Dividend Yield:
|